{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:28:28Z","timestamp":1793392108937,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003552.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T00:00:00Z","timestamp":1367280000000}}],"reference-count":81,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003552.pub4","type":"journal-article","created":{"date-parts":[[2013,4,28]],"date-time":"2013-04-28T03:25:01Z","timestamp":1367119501000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Skin patch and vaginal ring versus combined oral contraceptives for contraception"],"prefix":"10.1002","volume":"2013","author":[{"given":"Laureen M","family":"Lopez","sequence":"first","affiliation":[{"name":"FHI 360; Clinical Sciences; P.O. Box 13950 Research Triangle Park North Carolina USA 27709"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Grimes","sequence":"additional","affiliation":[{"name":"University of North Carolina, School of Medicine; Obstetrics and Gynecology; CB#7570 Chapel Hill North Carolina USA 27599-7570"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F","family":"Gallo","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention; Division of Reproductive Health; 4770 Buford Highway, Mail Stop K-34 Atlanta Georgia USA 30341-3724"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie L","family":"Stockton","sequence":"additional","affiliation":[{"name":"FHI360; Health Services Research; PO Box 13950 Research Triangle Park North Carolina USA 27709"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth F","family":"Schulz","sequence":"additional","affiliation":[{"name":"FHI 360 and UNC School of Medicine; Quantitative Sciences; P.O. Box 13950 Research Triangle Park North Carolina USA NC 27709"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD003552.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","article-title":"Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 3 \u00b5g of ethinyl estradiol and 3 mg of drospirenone","volume":"74","author":"Ahrendt","year":"2006","journal-title":"Contraception"},{"issue":"9","key":"10.1002\/14651858.CD003552.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/humrep\/del162","article-title":"Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 \u00b5g ethinyl estradiol and 3 mg drospirenone","volume":"21","author":"Milsom","year":"2006","journal-title":"Human Reproduction"},{"issue":"18","key":"10.1002\/14651858.CD003552.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial","volume":"285","author":"Audet","year":"2001","journal-title":"Journal of the American Medical Association"},{"issue":"9","key":"10.1002\/14651858.CD003552.pub4-BIB0004|cit4","first-page":"1715","article-title":"Comparison of cycle control and side effects between transdermal contraceptive patch and an oral contraceptive in women older than 35 years","volume":"90","author":"Boonyarangkul","year":"2007","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"1","key":"10.1002\/14651858.CD003552.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1067\/mob.2002.118844","article-title":"Transdermal contraception: evaluation of three transdermal norelgestromin\/ethinyl estradiol doses in a randomized, multicenter, dose-response study","volume":"186","author":"Dittrich","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD003552.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13625180400007199","article-title":"A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function","volume":"9","author":"Duijkers","year":"2004","journal-title":"European Journal of Contraception and Reproductive Health Care"},{"issue":"5","key":"10.1002\/14651858.CD003552.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.contraception.2007.08.001","article-title":"Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive","volume":"76","author":"Elkind-Hirsch","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD003552.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/AOG.0b013e3181cf45dc","article-title":"Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial","volume":"115","author":"Gilliam","year":"2010","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD003552.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"323 e1-7","DOI":"10.1016\/j.ajog.2010.05.039","article-title":"Daily context matters: predictors of missed oral contraceptive pills among college and graduate students","volume":"203","author":"Hughey","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD003552.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/humrep\/deh686","article-title":"Effects of two types of hormonal contraception--oral versus intravaginal--on the sexual life of women and their partners","volume":"20","author":"Guida","year":"2005","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD003552.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.contraception.2012.04.035","article-title":"Increased compliance with a low-dose combination contraceptive patch (AG200-15) compared with a low-dose combination oral contraceptive (COC) in a Phase 3 clinical trial (abstract)","volume":"86","author":"Kaunitz","year":"2012","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD003552.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.contraception.2012.05.106","article-title":"Increased compliance independent of patient demographics with a low-dose combination contraceptive patch (AG200-15) compared with a low-dose combination oral contraceptive in a Phase 3 clinical trial (abstract)","volume":"86","author":"Kaunitz","year":"2012","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0013|cit13","unstructured":"Kaunitz AM Mishell DR Foegh M Comparative Phase 3 study of AG200-15, a low-dose estrogen and levonorgestrel contraceptive patch http:\/\/www.agiletherapeutics.com\/Clinical_support.html"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003552.pub4-BIB0014|cit14","first-page":"B77","article-title":"Comparison of the effects of a contraceptive patch and oral contraceptives on coagulation parameters [abstract no. FC2.30.04]","volume":"70","author":"Kluft","year":"2000","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD003552.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.contraception.2007.10.004","article-title":"Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables","volume":"77","author":"Kluft","year":"2008","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD003552.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijgo.2011.03.008","article-title":"Combined contraceptive ring versus combined oral contraceptive (30-mug ethinylestradiol and 3-mg drospirenone)","volume":"114","author":"Mohamed","year":"2011","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD003552.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/humrep\/deh604","article-title":"Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 \u00b5g ethinylestradiol and 150 \u00b5g levonorgestrel: a randomized trial","volume":"20","author":"Oddsson","year":"2005","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD003552.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.contraception.2004.09.001","article-title":"Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial","volume":"71","author":"Oddsson","year":"2005","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD003552.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2005.12.007","article-title":"Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables","volume":"195","author":"Rad","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD003552.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2007.01.027","article-title":"Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen","volume":"75","author":"Sitruk-Ware","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD003552.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.contraception.2006.03.022","article-title":"Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives","volume":"74","author":"Sabatini","year":"2006","journal-title":"Contraception"},{"issue":"6","key":"10.1002\/14651858.CD003552.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jpag.2007.06.001","article-title":"Adolescent and young women's experience with the vaginal ring and oral contraceptive pills","volume":"20","author":"Stewart","year":"2007","journal-title":"Journal of Pediatric and Adolescent Gynecology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003552.pub4-BIB0023|cit23","first-page":"B78","article-title":"Comparison of efficacy, cycle control, compliance and safety in users of a contraceptive patch vs an oral contraceptive","volume":"70","author":"Hedon","year":"2000","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD003552.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejogrb.2005.01.021","article-title":"Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception","volume":"121","author":"Urdl","year":"2005","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD003552.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/01.AOG.0000136082.59644.13","article-title":"A comparison between the vaginal ring and oral contraceptives","volume":"104","author":"Veres","year":"2004","journal-title":"Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD003552.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.contraception.2005.05.008","article-title":"Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive","volume":"72","author":"O'Connell","year":"2005","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD003552.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.contraception.2005.11.003","article-title":"Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive","volume":"73","author":"Schafer","year":"2006","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD003552.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.AOG.0000164483.13326.59","article-title":"Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive","volume":"106","author":"Westhoff","year":"2005","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0029|cit29","doi-asserted-by":"crossref","unstructured":"Archer D Bigrigg A Smallwood G Shangold G Creasy G An integrated assessment of patient compliance with a weekly contraceptive patch (ORTHO EVRA \/ EVRA) Fertility and Sterility 2001 20","DOI":"10.1016\/S0015-0282(01)02082-9"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0015-0282(01)03263-0","article-title":"Assessment of compliance with a weekly contraceptive patch (Ortho Evra\u2122\/Evra\u2122) among North American women","volume":"77","author":"Archer","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2003.10.006","article-title":"The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy","volume":"69","author":"Archer","year":"2004","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD003552.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2008.02.012","article-title":"Effect of \"observed start\" vs. traditional \"Sunday start\" on hormonal contraceptive continuation rates after medical abortion","volume":"78","author":"Bednarek","year":"2008","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1067\/mob.2002.121103","article-title":"Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel\/ethinyl estradiol","volume":"186","author":"Bjarnadottir","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD003552.pub4-BIB0034|cit34","first-page":"37","article-title":"Combined hormonal contraception in cycles artificially extended","volume":"78","author":"Bustillos-Alamilla","year":"2010","journal-title":"Ginecolog\u00eda de Obstetricia de M\u00e9xico"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0035|cit35","doi-asserted-by":"crossref","unstructured":"Creasy G Hall N Shangold G Patient adherence with the contraceptive patch dosing schedule versus oral contraceptives Obstetrics and Gynecology 2000 S60","DOI":"10.1016\/S0029-7844(00)00716-X"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/humrep\/deh493","article-title":"Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study","volume":"19","author":"Duijkers","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1093\/humrep\/deh494","article-title":"Follicular growth during contraceptive pill or vaginal ring treatment depends on the day of ovulation in the pretreatment cycle","volume":"19","author":"Duijkers","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Guazzelli CA Barreiros FA Barbosa R Torloni MR Barbieri M Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism Contraception 2011","DOI":"10.1016\/j.contraception.2011.08.014"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0015-0282(01)01689-2","article-title":"Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition","volume":"75","author":"Mulders","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0020-7292(00)85163-2","article-title":"Effects of a contraceptive patch and 3 oral contraceptives on follicular development following incorrect dosing [abstract no. FC2.30.08]","volume":"70","author":"Pierson","year":"2000","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0041|cit41","first-page":"34","article-title":"Ortho Evra\/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error","volume":"80","author":"Pierson","year":"2003","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.fertnstert.2005.06.040","article-title":"Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive","volume":"85","author":"Roumen","year":"2006","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0015-0282(01)03264-2","article-title":"A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra\u2122\/Evra\u2122)","volume":"77","author":"Sibai","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD003552.pub4-BIB0044|cit44","first-page":"799","article-title":"Efficacy and safety of a transdermal contraceptive system","volume":"98","author":"Smallwood","year":"2001","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-200039030-00005","article-title":"Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring","volume":"39","author":"Timmer","year":"2000","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0048|cit47","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.ajog.2005.02.067","article-title":"Effect of oral versus transdermal steroidal contraceptives on androgenic markers","volume":"192","author":"White","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0047|cit48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.contraception.2006.04.005","article-title":"Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins","volume":"74","author":"White","year":"2006","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0015-0282(01)03262-9","article-title":"Integrated summary of Ortho Evra\u2122\/Evra\u2122 contraceptive patch adhesion in varied climates and conditions","volume":"77","author":"Zacur","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\u2122\/Evra\u2122 transdermal system","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0051|cit51","unstructured":"Agile Therapeutics Transdermal contraceptive delivery system (TCDS) of levonorgestrel and ethinyl estradiol (ATI-CL13) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01236768"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0052|cit52","unstructured":"Bayer Healthcare AG US cycle control and blood pressure study http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00920985"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0053|cit53","unstructured":"Weisberg E Comparative 12 month study of menstrually-signalled use of a combined contraceptive pill versus a combined contraceptive vaginal ring http:\/\/www.anzctr.org.au\/ACTRN12609000391279.aspx"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0055|cit55","unstructured":"Bayer Healthcare AG Inhibition of ovulation and pharmacokinetics of transdermal ethinylestradiol (EE) and gestodene (GSD) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00915915 NCT00915915"},{"issue":"3","key":"10.1002\/14651858.CD003552.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.contraception.2012.08.037","article-title":"Current status of contraceptive vaginal rings","volume":"87","author":"Brache","year":"2013","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0057|cit57","unstructured":"CONSORT group CONSORT: Transparent reporting of trials http:\/\/www.consort-statement.org\/"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0059|cit59","unstructured":"US Food Drug Administration Ortho Evra (norelgestromin\/ethinyl estradiol) information http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm110402.htm"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.contraception.2009.06.005","article-title":"Forgettable contraception","volume":"80","author":"Grimes","year":"2009","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/009286159803200102","article-title":"Technologies for automating randomized treatment assignment in clinical trials","volume":"32","author":"Haag","year":"1998","journal-title":"Drug Information Journal"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study","volume":"143","author":"Heit","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0063|cit63","first-page":"101","article-title":"Pharmacology of progestins: 17alpha-hydroxyprogesterone derivatives and progestins of the first and second generation","volume-title":"Progestins and Antiprogestins in Clinical Practice","author":"Henzl","year":"2000"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0064|cit64","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD003552.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/AOG.0b013e3181eb6b0f","article-title":"Using daily text-message reminders to improve adherence with oral contraceptives","volume":"116","author":"Hou","year":"2010","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0066|cit66","doi-asserted-by":"crossref","unstructured":"Jensen JT Vaginal ring delivery of selective progesterone receptor modulators for contraception Contraception 2013 314 8","DOI":"10.1016\/j.contraception.2012.08.038"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0067|cit67","doi-asserted-by":"crossref","unstructured":"Langston AM Rosario L Westhoff CL Structured contraceptive counseling--a randomized controlled trial Patient Education and Counseling 2010 362 7","DOI":"10.1016\/j.pec.2010.08.006"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0068|cit68","doi-asserted-by":"crossref","unstructured":"Lete I Doval JL Perez-Campos E Lertxundi R Correa M de la Viuda E Self-described impact of noncompliance among users of a combined hormonal contraceptive method Contraception 2008 276 82","DOI":"10.1016\/j.contraception.2007.11.009"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0071|cit71","unstructured":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) A multi-center, open-label, randomized, parallel group study to evaluate pharmacokinetic profile, effects on the mechanisms of contraceptive efficacy and safety of two progestin-only patches containing different doses of levonorgestrel (LNG) (CCN009) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01166412 NCT01166412"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0072|cit72","unstructured":"Population Council Licensing Opportunities http:\/\/www.popcouncil.org\/what\/licensing.asp#\/jQueryUITabs1-2"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2307\/2136191","article-title":"Measuring compliance among oral contraceptive users","volume":"28","author":"Potter","year":"1996","journal-title":"Family Planning Perspectives"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0074|cit74","doi-asserted-by":"crossref","unstructured":"Raymond EG Burke AE Espey E Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective Obstetrics and Gynecology 2012 1039 44","DOI":"10.1097\/AOG.0b013e31825194ca"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2307\/2991665","article-title":"Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation","volume":"30","author":"Rosenberg","year":"1998","journal-title":"Family Planning Perspectives"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003552.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2012.08.002","article-title":"Contraception technology: past, present and future","volume":"87","author":"Sitruk-Ware","year":"2013","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD003552.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/HMBCI.2011.004","article-title":"Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinylestradiol and levonorgestrel","volume":"6","author":"Stanczyk","year":"2011","journal-title":"Hormone Molecular Biology and Clinical Investigation"},{"key":"10.1002\/14651858.CD003552.pub4-BIB0080|cit80","volume-title":"Evidence-based Medicine: How to Practice and Teach EBM","author":"Strauss","year":"2005"},{"issue":"5","key":"10.1002\/14651858.CD003552.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003552.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T13:15:43Z","timestamp":1744118143000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003552.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Fertility Regulation Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":81,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003552.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,30]]}}}